| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Animal studies of prophylaxis
|
Black, Roberta J.
|
|
1997
|
102 |
5S2 |
p. 39-44
6 p.
|
artikel
|
| 2 |
Candidate antiretroviral agents for use in postexposure prophylaxis
|
Saag, Michael S.
|
|
1997
|
102 |
5S2 |
p. 25-31
7 p.
|
artikel
|
| 3 |
Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood — France, United Kingdom, and United States, January 1988–August 1994
|
|
|
1997
|
102 |
5S2 |
p. 47-51
5 p.
|
artikel
|
| 4 |
Combination chemotherapy for Human Immunodeficiency Virus-1
|
Manion, Douglas J.
|
|
1997
|
102 |
5S2 |
p. 76-80
5 p.
|
artikel
|
| 5 |
Discussion: Postexposure follow-up — Duration and counseling
|
|
|
1997
|
102 |
5S2 |
p. 125-126
2 p.
|
artikel
|
| 6 |
Discussion: To what extent do these data indicate that postexposure prophylaxis with zidovudine is effective in humans?
|
|
|
1997
|
102 |
5S2 |
p. 56-57
2 p.
|
artikel
|
| 7 |
Discussion: What are the optimal regimens for postexposure chemoprophylaxis?
|
|
|
1997
|
102 |
5S2 |
p. 81-82
2 p.
|
artikel
|
| 8 |
Discussion: Zidovudine toxicity in uninfected healthcare workers
|
|
|
1997
|
102 |
5S2 |
p. 68-69
2 p.
|
artikel
|
| 9 |
Duration of time between exposure and seroconversion in healthcare workers with occupationally acquired infection with human immunodeficiency virus
|
Ciesielski, Carol A.
|
|
1997
|
102 |
5S2 |
p. 115-116
2 p.
|
artikel
|
| 10 |
Editorial note in March 1997; combination chemotherapy
|
Gerberding, Julie L.
|
|
1997
|
102 |
5S2 |
p. 83-84
2 p.
|
artikel
|
| 11 |
Efficacy of zidovudine in preventing HIV transmission from mother to infant
|
Balsley, James
|
|
1997
|
102 |
5S2 |
p. 45-46
2 p.
|
artikel
|
| 12 |
Emergency medical services
|
Arndt, Sharon Doyle
|
|
1997
|
102 |
5S2 |
p. 104-105
2 p.
|
artikel
|
| 13 |
Failures of zidovudine postexposure prophylaxis
|
Jochimsen, Elise M.
|
|
1997
|
102 |
5S2 |
p. 52-55
4 p.
|
artikel
|
| 14 |
General discussion: Postexposure prophylaxis
|
|
|
1997
|
102 |
5S2 |
p. 113-114
2 p.
|
artikel
|
| 15 |
Human immunodeficiency virus postexposure management of healthcare workers: Report of a workshop
|
Bell, David M.
|
|
1997
|
102 |
5S2 |
p. 1-3
3 p.
|
artikel
|
| 16 |
Immune response to human immunodeficiency virus (HIV) in healthcare workers occupationally exposed to HIV-contaminated blood
|
Pinto, Ligia A.
|
|
1997
|
102 |
5S2 |
p. 21-24
4 p.
|
artikel
|
| 17 |
Issues complicating the implementation of postexposure prophylaxis
|
L'Ecuyer, Paul B.
|
|
1997
|
102 |
5S2 |
p. 90-94
5 p.
|
artikel
|
| 18 |
Legal and ethical issues in revising human immunodeficiency virus postexposure protocols
|
Barnes, Mark
|
|
1997
|
102 |
5S2 |
p. 111-112
2 p.
|
artikel
|
| 19 |
Morbidity and mortality weekly report
|
|
|
1997
|
102 |
5S2 |
p. 4-8
5 p.
|
artikel
|
| 20 |
Occupational risk of human immunodeficiency virus infection in healthcare workers: An overview
|
Bell, David M.
|
|
1997
|
102 |
5S2 |
p. 9-15
7 p.
|
artikel
|
| 21 |
Perspectives of healthcare workers
|
Cohen, Jamie
|
|
1997
|
102 |
5S2 |
p. 102-103
2 p.
|
artikel
|
| 22 |
Postexposure chemoprophylaxis against HIV: what are the implications for people with AIDS and the organizations that serve them?
|
Hodel, Derek
|
|
1997
|
102 |
5S2 |
p. 106-110
5 p.
|
artikel
|
| 23 |
Postexposure prophylaxis for human immunodeficiency virus at San Francisco General Hospital
|
Gerberding, Julie L.
|
|
1997
|
102 |
5S2 |
p. 85-89
5 p.
|
artikel
|
| 24 |
Postexposure prophylaxis implementation issues: Programmatic concerns in hospitals
|
Catalano, Michela T.
|
|
1997
|
102 |
5S2 |
p. 95-97
3 p.
|
artikel
|
| 25 |
Prevalence and incidence of resistance to zidovudine and other antiretroviral drugs
|
Mayers, Douglas L.
|
|
1997
|
102 |
5S2 |
p. 70-75
6 p.
|
artikel
|
| 26 |
Principles of clinical pharmacology in postexposure prophylaxis
|
Flexner, Charles W.
|
|
1997
|
102 |
5S2 |
p. 32-38
7 p.
|
artikel
|
| 27 |
Recommendations for chemoprophylaxis after occupational exposure to human immunodeficiency virus: A public health agency perspective
|
Danila, Richard N.
|
|
1997
|
102 |
5S2 |
p. 98-101
4 p.
|
artikel
|
| 28 |
The role of skin dendritic cells in the initiation of human immunodeficiency virus infection
|
Blauvelt, Andrew
|
|
1997
|
102 |
5S2 |
p. 16-20
5 p.
|
artikel
|
| 29 |
Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure
|
Busch, Michael P.
|
|
1997
|
102 |
5S2 |
p. 117-124
8 p.
|
artikel
|
| 30 |
Toxicity of antiretroviral agents
|
Struble, Kimberly A.
|
|
1997
|
102 |
5S2 |
p. 65-67
3 p.
|
artikel
|
| 31 |
Zidovudine safety and tolerance among uninfected healthcare workers: A brief update
|
Beekmann, Susan E.
|
|
1997
|
102 |
5S2 |
p. 63-64
2 p.
|
artikel
|
| 32 |
Zidovudine toxicity in uninfected healthcare workers
|
Ippolito, Giuseppe
|
|
1997
|
102 |
5S2 |
p. 58-62
5 p.
|
artikel
|
Tijdschrift beschrijving